HIGHLIGHTS
SUMMARY
In PD, an increased mortality rate was associated with SARS-CoV-2 infection, and an increased hospitalization and mortality rate has been shown for patients with AD (McAlpine et_al 2021; Zhang et_al 2020, 2021a). Data on the clinical outcome of SARS-CoV-2 infections on patients with other neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), or Huntington Disease (HD) are yet limited and will require further studies in the course of the pandemic (De Marchi et_al 2021; Musson et_al 2022). Chronic neurological diseases such as multiple_sclerosis with increased disability and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.